Skip to content

Gait retraining interventions for medial knee osteoarthritis.

The effect of gait retraining interventions on patient-reported outcomes and proxy measures of medial knee load in individuals with medial knee osteoarthritis (OA).

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621000414819
Enrollment
70
Registered
2021-04-15
Start date
2021-05-26
Completion date
2024-06-30
Last updated
2024-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary objective of this 3- arm randomised controlled trial, is to evaluate the effects of gait retraining interventions on proxy measures of medial knee load (early- and late-stance peak KAM, KAM impulse, and varus thrust) in people with medial knee osteoarthritis. This will be assessed at baseline, six weeks after the initial assessment and three months following this.

Interventions

• Participants will be randomly allocated to either a toe-in, toe-out, or postural re-education gait retraining program for six weeks, followed by a booster session between the end of the intervention and the 3-month follow-up. The intervention program will be delivered by either a physiotherapist or podiatrist with a minimum of three years of experience. • Participants will be required to attend the 3D gait analysis laboratory three times for the biomechanics assessment. The biomechanical asses

• Participants will be randomly allocated to either a toe-in, toe-out, or postural re-education gait retraining program for six weeks, followed by a booster session between the end of the intervention and the 3-month follow-up. The intervention program will be delivered by either a physiotherapist or podiatrist with a minimum of three years of experience. • Participants will be required to attend the 3D gait analysis laboratory three times for the biomechanics assessment. The biomechanical assessment will involve the placement of reflective markers on the upper body and lower limb anatomical landmarks followed by the completion of five successful gait trials (clean foot strike for the most symptomatic limb). This assessment will be conducted at baseline, immediately following the 6-week intervention program and three months following the 6-week program. • The first session will run for 1.5-2 hours as this will involve baseline biomechanical assessments, education for the participant, and commencement of the intervention program (week 0). Overall, participants will be receiving 4-6 supervised sessions over the initial 6 weeks, with the frequency determined by the therapist delivering the intervention. • These sessions will consist of supervised one-on-one gait retraining sessions of 30 minutes, motivational interviewing, goal-setting, and walking with the altered foot progression angle (FPA)/ upright trunk. Sessions outline: In weeks 1-2, participants in all groups will aim to walk with altered foot progression angle (FPA) using the spatiotemporal Zeno Walkway or the OPAL wearable sensors. In weeks 2-4, participants will achieve walking with altered FPA or more upright trunk while dual-tasking (simple cognitive tasks involving counting backward in 3's). In weeks 5-6, participants will achieve walking with altered FPA, or more upright trunk whilst walking outdoors/various terrain using the OPAL wearable sensors. In addition to these supervised sessions during the 6- week period, participants will also be prescribed 30 minutes of their allocated gait strategy to practice each day at home. A logbook will be provided for participants to record adherence and any adverse events. Attendance will also be recorded by the physiotherapist or podiatrist delivering the intervention. • Participants will be invited to a gait retraining session between finishing the intervention period and their final assessment (3 months post-intervention). Participants will be asked to attend a gait retraining booster session at week 12 but can be completed between weeks 9-15. During this session, participants will get a chance to obtain qualitative and quantitative feedback from the therapist regarding their prescribed gait change.

Sponsors

A. Prof Milena Simic (CI)
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

People will be included if they display clinical signs of knee OA according to the National Institute for Health and Care Excellence (NICE) guidelines, which involves being 45 years old or older, having activity-related joint pain, and having either no morning joint-related stiffness or morning stiffness that lasts no longer than 30 mins. Participants will be included if they report medial knee pain, and average knee pain of greater or equal to 1/10 on a visual analog scale (VAS) with 0 representing no pain, and 10 representing worst pain imaginable. Participants will be included if they are able to walk unaided for at least 30 mins and display evidence of knee OA based on clinical screening according to the American College of Rheumatology (ACR) Clinical Classification for Knee Osteoarthritis.

Exclusion criteria

History of knee arthroplasty within the past 6 months, history of joint replacement surgery involving the knee or hip of the affected side, neurological conditions affecting ambulation, other systematic rheumatologic conditions affecting joints (e.g.: rheumatoid arthritis), spinal pain with lower limb symptoms, BMI 35 kg/m^2, self-reported genu valgum alignment.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 8, 2026